Search by Drug Name or NDC
NDC 59779-0334-08 Headache Relief 250; 250; 65 mg/1; mg/1; mg/1 Details
Headache Relief 250; 250; 65 mg/1; mg/1; mg/1
Headache Relief is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by CVS Pharmacy. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
NDC | 59779-0334 |
---|---|
Product ID | 59779-334_4237de73-bb26-4032-aab9-a420c72000ca |
Associated GPIs | 64990003200350 |
GCN Sequence Number | 040186 |
GCN Sequence Number Description | aspirin/acetaminophen/caffeine TABLET 250-250-65 ORAL |
HIC3 | H3D |
HIC3 Description | ANALGESIC/ANTIPYRETICS, SALICYLATES |
GCN | 10414 |
HICL Sequence Number | 001807 |
HICL Sequence Number Description | ASPIRIN/ACETAMINOPHEN/CAFFEINE |
Brand/Generic | Generic |
Proprietary Name | Headache Relief |
Proprietary Name Suffix | Extra Strength |
Non-Proprietary Name | Acetaminophen, Aspirin and Caffeine |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, FILM COATED |
Route | ORAL |
Active Ingredient Strength | 250; 250; 65 |
Active Ingredient Units | mg/1; mg/1; mg/1 |
Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
Labeler Name | CVS Pharmacy |
Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH DRUG |
Application Number | M013 |
Listing Certified Through | 2024-12-31 |
Package
NDC 59779-0334-08 (59779033408)
NDC Package Code | 59779-334-08 |
---|---|
Billing NDC | 59779033408 |
Package | 1 BOTTLE, PLASTIC in 1 CARTON (59779-334-08) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
Marketing Start Date | 2008-03-13 |
NDC Exclude Flag | N |
Pricing Information | N/A |